RxDoctor Payments Data

Steven Paul

Psychiatry · Carmel, INNPI 1124387865

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (50.3%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 3 manufacturers reported payments, led by Sage Therapeutics, LLC at 50.3% of the total. Reporting peaked in 2021 at $1,004,770 and has fallen 96.2% since, to $38,183 in 2025. Among psychiatry clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,930,784in general payments, 2019–2025

Across 53 payments — averaging $55,298 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sage Therapeutics, LLC$1.5M
  • Alnylam Pharmaceuticals Inc.$1.4M
  • E.r. Squibb & Sons, L.L.C.$11K

What the payments were for

  • Consulting fees$1,454,30850%
  • Speaking & faculty fees$1,474,15650%
  • Travel & lodging$6540%
  • Food & beverage$1,4130%
  • Gifts$2530%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sage Therapeutics, LLC23$1,475,038
Alnylam Pharmaceuticals Inc.29$1,444,675
E.r. Squibb & Sons, L.L.C.1$11,071

How this compares

$2,930,784 in reported general payments places this provider in the 95th percentile of 514 psychiatry providers in Indiana.

See all psychiatry providers in Indiana

Other psychiatry in Carmel

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →